NCT00385177View on ClinicalTrials.gov

Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

May 31, 2009

Conditions
Breast NeoplasmsColorectal NeoplasmsPancreatic NeoplasmsPelvic NeoplasmsLung Neoplasms
Interventions
DRUG

SN2310 Injectable Emulsion

Escalating doses given IV every three weeks

Trial Locations (2)

19111

Fox Chase Cancer Center, Philadelphia

37203

Sarah Cannon Research Institute, Nashville

Sponsors
All Listed Sponsors
lead

Achieve Life Sciences

INDUSTRY